Akari Therapeutics News

Akari Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

May 2 05:32

Akari Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Mar 12 05:28

Akari Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Mar 6 06:01

Akari Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Mar 5 21:37

Akari Therapeutics | 424B3: Prospectus

Oct 28, 2023 04:15

Akari Therapeutics | EFFECT: Others

Oct 27, 2023 12:15

Akari Therapeutics | EFFECT: Others

Oct 24, 2023 12:15

Akari Therapeutics | EFFECT: Others

Oct 24, 2023 12:15

Akari Therapeutics | EFFECT: Others

Jun 7, 2023 12:15

Akari Therapeutics | EFFECT: Others

Jun 7, 2023 12:15

Akari Therapeutics | 424B5: Prospectus

Mar 31, 2023 22:29

Akari Therapeutics | 424B3: Prospectus

Nov 10, 2022 05:11

Akari Therapeutics | EFFECT: Others

Nov 9, 2022 13:15

Akari Therapeutics | 424B5: Prospectus

Sep 15, 2022 00:19

Akari Therapeutics | 424B5: Prospectus

Mar 10, 2022 10:39

Akari Therapeutics | 424B5: Prospectus

Jan 4, 2022 10:41

Akari Therapeutics | EFFECT: Others

Oct 4, 2021 12:15

Akari Therapeutics | EFFECT: Others

Oct 4, 2021 12:15

Akari Therapeutics | EFFECT: Others

Oct 4, 2021 12:15

Akari Therapeutics | EFFECT: Others

Oct 4, 2021 12:15